XML 55 R44.htm IDEA: XBRL DOCUMENT v3.25.3
STOCKHOLDERS' EQUITY - Narrative (Details)
1 Months Ended 3 Months Ended 9 Months Ended
Aug. 31, 2024
USD ($)
$ / shares
shares
Sep. 30, 2025
USD ($)
$ / shares
year
shares
Jun. 30, 2025
USD ($)
$ / shares
shares
Mar. 31, 2025
USD ($)
$ / shares
year
shares
Sep. 30, 2024
shares
Mar. 31, 2024
shares
Sep. 30, 2025
USD ($)
$ / shares
year
shares
Sep. 30, 2024
USD ($)
Dec. 31, 2024
$ / shares
Stockholders’ Equity [Line Items]                  
Issuance of common stock upon exercise of warrants (in shares) | shares     40,000            
Exercise price (in dollars per share)   $ 7.50         $ 7.50   $ 12.63
Proceeds from the exercise of warrants, net | $             $ 10,482,000 $ 1,983,000  
Warrants, issued (in shares) | shares             5,310,676    
Gross proceeds from issuances of common stock | $             $ 3,000,000.0    
Stock issuance costs | $             299,000    
Remaining borrowing capacity | $   $ 7,500,000         $ 7,500,000    
Series H                  
Stockholders’ Equity [Line Items]                  
Issuance of common stock upon exercise of warrants (in shares) | shares   1,458,872 1,458,872            
Exercise price (in dollars per share)   $ 4.15         $ 4.15    
Sale of stock, price per share (in dollars per share)   $ 0.125 $ 0.125       $ 0.125    
Proceeds from the exercise of warrants, net | $   $ 274,000 $ 182,000            
Warrants, issued (in shares) | shares             1,458,872    
Warrant exercise, gross proceeds | $   6,300,000 4,500,000            
Warrant exercise, issuance cost | $   $ 685,000 $ 526,000            
Series H | Maximum                  
Stockholders’ Equity [Line Items]                  
Number of warrants (in shares) | shares     1,458,872            
Series H | Measurement Input, Share Price                  
Stockholders’ Equity [Line Items]                  
Warrants, fair value, measurement input   5.09         5.09    
Series H | Measurement Input, Price Volatility                  
Stockholders’ Equity [Line Items]                  
Warrants, fair value, measurement input   1.14         1.14    
Series H | Measurement Input, Expected Term                  
Stockholders’ Equity [Line Items]                  
Warrants, fair value, measurement input | year   1.3         1.3    
Series H | Measurement Input, Expected Dividend Rate                  
Stockholders’ Equity [Line Items]                  
Warrants, fair value, measurement input   0         0    
Series H | Measurement Input, Risk Free Interest Rate                  
Stockholders’ Equity [Line Items]                  
Warrants, fair value, measurement input   0.037         0.037    
Original Warrants                  
Stockholders’ Equity [Line Items]                  
Exercise price (in dollars per share) $ 2.90                
Warrant exercise, gross proceeds | $ $ 1,100,000                
Warrant exercise, issuance cost | $ $ 250,000                
Modification of terms related to certain warrants | $       $ 58,000          
Series F-1                  
Stockholders’ Equity [Line Items]                  
Exercise price (in dollars per share) $ 4.35 $ 4.35         $ 4.35    
Warrants, issued (in shares) | shares 251,884           0    
Weighted average remaining life 4 years 6 months                
Series F-1 | Measurement Input, Share Price                  
Stockholders’ Equity [Line Items]                  
Warrants, fair value, measurement input       2.38          
Series F-1 | Measurement Input, Price Volatility                  
Stockholders’ Equity [Line Items]                  
Warrants, fair value, measurement input       1.20          
Series F-1 | Measurement Input, Expected Term                  
Stockholders’ Equity [Line Items]                  
Warrants, fair value, measurement input | year       4.5          
Series F-1 | Measurement Input, Expected Dividend Rate                  
Stockholders’ Equity [Line Items]                  
Warrants, fair value, measurement input       0          
Series F-1 | Measurement Input, Risk Free Interest Rate                  
Stockholders’ Equity [Line Items]                  
Warrants, fair value, measurement input       0.040          
Series F-2                  
Stockholders’ Equity [Line Items]                  
Exercise price (in dollars per share) $ 4.35 $ 4.35         $ 4.35    
Warrants, issued (in shares) | shares 122,834           0    
Weighted average remaining life 1 year                
Series F-2 | Measurement Input, Share Price                  
Stockholders’ Equity [Line Items]                  
Warrants, fair value, measurement input       2.38          
Series F-2 | Measurement Input, Price Volatility                  
Stockholders’ Equity [Line Items]                  
Warrants, fair value, measurement input       1.11          
Series F-2 | Measurement Input, Expected Term                  
Stockholders’ Equity [Line Items]                  
Warrants, fair value, measurement input | year       1          
Series F-2 | Measurement Input, Expected Dividend Rate                  
Stockholders’ Equity [Line Items]                  
Warrants, fair value, measurement input       0          
Series F-2 | Measurement Input, Risk Free Interest Rate                  
Stockholders’ Equity [Line Items]                  
Warrants, fair value, measurement input       0.040          
Series F-1, Series F-2 and Dealer Manager Warrants                  
Stockholders’ Equity [Line Items]                  
Warrants, issued (in shares) | shares       1,517,608          
Common Stock                  
Stockholders’ Equity [Line Items]                  
Issuance of common stock upon exercise of warrants (in shares) | shares   1,458,872 1,498,872 374,718 505,502 460      
Issuance of common stock, net of issuance costs (in shares) | shares     489,341 365,319     854,660